mRNA-3705

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-3705, covering 2025-12-23 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia [Phase 1, Phase 2]

See pricing